Principal Street Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.79M Sell
94,666
-1,586
-2% -$142K 1.43% 12
2026
Q1
$6.91M Buy
96,252
+471
+0.5% +$36.3K 1.13% 36
2025
Q4
$7.6M Sell
95,781
-635
-0.7% -$50.1K 1.28% 22
2025
Q3
$7.27M Buy
96,416
+44,557
+86% +$3.05M 1.16% 22
2025
Q2
$3.58M Buy
+51,859
New +$3.4M 0.35% 67
2023
Q1
Sell
-2,678
Closed -$250K 227
2022
Q4
$250K Buy
2,678
+146
+6% +$14.1K 0.06% 198
2022
Q3
$241K Buy
2,532
+190
+8% +$18.8K 0.06% 181
2022
Q2
$217K Buy
2,342
+55
+2% +$5.37K 0.06% 195
2022
Q1
$231K Buy
2,287
+175
+8% +$18.4K 0.05% 196
2021
Q4
$218K Buy
+2,112
New +$195K 0.05% 190
2021
Q2
Sell
-9,800
Closed -$737K 216
2021
Q1
$737K Buy
9,800
+5,872
+149% +$428K 0.1% 144
2020
Q4
$268K Buy
3,928
+250
+7% +$16.3K 0.08% 153
2020
Q3
$215K Buy
+3,678
New +$229K 0.08% 147
2020
Q2
Sell
-16,664
Closed -$988K 132
2020
Q1
$988K Buy
+16,664
New +$1.11M 0.41% 50
2019
Q3
Sell
-31,434
Closed -$1.71M 174
2019
Q2
$1.71M Sell
31,434
-44,059
-58% -$2.37M 0.95% 35
2019
Q1
$4.07M Buy
+75,493
New +$4.66M 1.77% 38

Other funds holding CVS

Principal Street Partners's CVS Position: Q2 2026 in Review

Principal Street Partners reduced its CVS Health (CVS) stake by 1.6% in Q2 2026, selling an estimated $142K and leaving 94,666 shares worth $9.79M. The position accounts for 1.43% of the portfolio, ranked #12.

Principal Street Partners first reported a position in CVS in Q1 2019 and has held it in 16 quarters since. 2,070 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Principal Street Partners held 94,666 shares of CVS Health worth $9.79M as of Q2 2026.
  • Principal Street Partners sold 1,586 CVS Health shares in Q2 2026, an estimated $142K.
  • CVS Health made up 1.43% of Principal Street Partners's portfolio in Q2 2026, its #12 holding.
  • Principal Street Partners first reported a position in CVS Health in Q1 2019 and has held it in 16 quarters since.
  • 2,070 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Principal Street Partners's 13F filing for Q2 2026, filed 14 Aug 2026.